MENINGITIS CANDIDA

MENINGITIS CANDIDA was reported 70 times

These drug classes are most commonly taken by patients reporting MENINGITIS CANDIDA:

# Drug Count
0 Corticosteroid [EPC] 45
1 Glycopeptide Antibacterial [EPC] 25
2 Penem Antibacterial [EPC] 23
3 Nitroimidazole Antimicrobial [EPC] 18
4 Fluoroquinolone Antibacterial [EPC] 10
5 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 10
6 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 10
7 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 10
8 Alkylating Drug [EPC] 7
9 Nonsteroidal Anti-inflammatory Drug [EPC] 7
10 Azole Antifungal [EPC] 6
11 Platelet Aggregation Inhibitor [EPC] 6
12 CD20-directed Cytolytic Antibody [EPC] 5
13 Lipid-based Polyene Antifungal [EPC] 5
14 Nucleoside Metabolic Inhibitor [EPC] 5
15 Polyene Antifungal [EPC] 5
16 Calcineurin Inhibitor Immunosuppressant [EPC] 4
17 General Anesthetic [EPC] 4
18 Platinum-based Drug [EPC] 4
19 Angiotensin 2 Receptor Blocker [EPC] 3
20 Calcium Channel Blocker [EPC] 3
21 Diagnostic Dye [EPC] 3
22 Dihydropyridine Calcium Channel Blocker [EPC] 3
23 Folate Analog Metabolic Inhibitor [EPC] 2
24 Interleukin-1 Receptor Antagonist [EPC] 2
25 Interleukin-6 Antagonist [EPC] 2
26 Interleukin-6 Receptor Antagonist [EPC] 2
27 Nucleoside Analog Antifungal [EPC] 2
28 Purine Antimetabolite [EPC] 2
29 Topoisomerase Inhibitor [EPC] 2
30 Aminoglycoside Antibacterial [EPC] 1
31 Antimetabolite Immunosuppressant [EPC] 1
32 Asparagine-specific Enzyme [EPC] 1
33 CD22-directed Immunoconjugate [EPC] 1
34 Complement Inhibitor [EPC] 1
35 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
36 Hepatitis C Virus NS5A Inhibitor [EPC] 1
37 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
38 Leukocyte Growth Factor [EPC] 1
39 Opioid Agonist [EPC] 1
40 Partial Opioid Agonist [EPC] 1
41 Rifamycin Antibacterial [EPC] 1
42 Sulfonamide Antimicrobial [EPC] 1
43 Tetracycline-class Antibacterial [EPC] 1
44 Tumor Necrosis Factor Blocker [EPC] 1